MariTide, a groundbreaking weight loss medication, shows 16% weight reduction in trials. Learn about this promising monthly ...

Monthly weight-loss shots on the horizon! Learn about new drugs like MariTide and why Black participation in clinical trials ...

A new study reveals that weight lost with GLP-1 drugs, such as semaglutide, is regained within a year after stopping ...

A new scientific study into the weight loss drug Mounjaro has found that it may not lead to a worrying side effect as ...

Novo Nordisk is in the lead, but not alone. Obesity doctors say they are gearing up for demand, predicted to be high. Some ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

Online pharmacies are no longer allowed to run adverts for weight loss injections, the advertising watchdog has ruled.

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

Experts are warning anyone experiencing GLP-1 drug side effects to report them after launching an investigation into their safety.

New guidance helps GPs manage patients using privately obtained weight-loss injections, addressing gaps in support like ...